Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer’s Disease
Marta Campora, Claudio Canale, Elena Gatta, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 3, pp. 447-461
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Quinones as Neuroprotective Agents
Ángel Cores, Noelia Carmona-Zafra, José Clerigué, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1464-1464
Open Access | Times Cited: 40
The Relevance and Insights on 1,4-Naphthoquinones as Antimicrobial and Antitumoral Molecules: A Systematic Review
Gabriela Navarro-Tovar, Sarai Vega‐Rodríguez, Elisa Leyva, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 496-496
Open Access | Times Cited: 21
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease
Da-Jiang Zou, Renzheng Liu, Yangjing Lv, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 14
Direct Functionalization of para‐Quinones: A Historical Review and New Perspectives
Raushan Kumar Jha, Sangit Kumar
European Journal of Organic Chemistry (2024) Vol. 27, Iss. 27
Closed Access | Times Cited: 5
Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's disease: synthesis, pharmacology, toxicity and docking studies
Muhammad Aamir Javed, Saba Bibi, Muhammad Saeed Jan, et al.
RSC Advances (2022) Vol. 12, Iss. 35, pp. 22503-22517
Open Access | Times Cited: 23
Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer's disease
Michele Tonelli, Marco Catto, Raimon Sabaté, et al.
European Journal of Medicinal Chemistry (2023) Vol. 250, pp. 115169-115169
Open Access | Times Cited: 13
The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer’s Disease Etiopathology
Hugo Fanlo-Ucar, Pol Picón-Pagès, Víctor Herrera-Fernández, et al.
Antioxidants (2024) Vol. 13, Iss. 10, pp. 1208-1208
Open Access | Times Cited: 3
Synthesis, Biological Evaluation, and In Silico Studies of New Acetylcholinesterase Inhibitors Based on Quinoxaline Scaffold
Paptawan Suwanhom, Jirakrit Saetang, Pasarat Khongkow, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4895-4895
Open Access | Times Cited: 29
Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease
Wenwu Liu, Xin Liu, Wenjie Liu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 114095-114095
Closed Access | Times Cited: 24
Synthesis, Biological Activity, and Molecular Modelling Studies of Naphthoquinone Derivatives as Promising Anticancer Candidates Targeting COX-2
Povilas Kavaliauskas, Felipe Stambuk, Waldo Acevedo, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 541-541
Open Access | Times Cited: 16
Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity
Omar M. Al-Saad, Moustafa T. Gabr, Sarah S. Darwish, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116266-116266
Open Access | Times Cited: 2
Novel Lawsone–Quinoxaline Hybrids as New Dual Binding Site Acetylcholinesterase Inhibitors
Paptawan Suwanhom, Teerapat Nualnoi, Pasarat Khongkow, et al.
ACS Omega (2023)
Open Access | Times Cited: 7
Citronellal as a Promising Candidate for Alzheimer’s Disease Treatment: A Comprehensive Study on In Silico and In Vivo Anti-Acetylcholine Esterase Activity
Krishna Chaitanya Pavani, DSNBK Prasanth, Murthy K.R. Shadakshara, et al.
Metabolites (2023) Vol. 13, Iss. 11, pp. 1133-1133
Open Access | Times Cited: 7
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE)
Rosalba Leuci, Leonardo Brunetti, Antonio Laghezza, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 958-958
Open Access | Times Cited: 11
Visible-light-promoted iron-catalyzed C–H functionalization of 1,4-naphthoquinones via oxidative coupling with sulfoximines
Alpa Sharma, Harpreet Kour, Jaspreet Kour, et al.
Chemical Communications (2022) Vol. 58, Iss. 80, pp. 11312-11315
Closed Access | Times Cited: 11
Molecular Deformation Is a Key Factor in Screening Aggregation Inhibitor for Intrinsically Disordered Protein Tau
Keke Chai, Jian Yang, Ying Tu, et al.
ACS Central Science (2024) Vol. 10, Iss. 3, pp. 717-728
Open Access | Times Cited: 1
Recent advances in the natural product analogues for the treatment of neurodegenerative diseases
Jinling Zhang, Peng Jiang, Shuping Wang, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107819-107819
Closed Access | Times Cited: 1
A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE)
Tereza Cristina Santos Evangelista, Óscar López, Adrián Puerta, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2395-2402
Open Access | Times Cited: 9
The cyclic peptide G4CP2 enables the modulation of galactose metabolism in yeast by interfering with GAL4 transcriptional activity
Stefano Rosa, Andrea Tagliani, Chiara Bertaso, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 3
Crystalline aloe-emodin reduce β-amyloid-induced toxicity in Caenorhabditis elegans with visualization of ingestion
Ruoyi Wang, Guiling Liang, Wen-Wu Tan, et al.
Journal of Molecular Structure (2024) Vol. 1311, pp. 138446-138446
Closed Access
Analysis of the anti-Alzheimer potential of bioactive compounds from Citrus hystrix DC. peel, leaf, and essential oil by network pharmacology
Adhisa Fathirisari Putri, Didik Huswo Utomo, Woro Anindito Sri Tunjung, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33496-e33496
Open Access
Pterostilbene: A natural neuroprotective stilbene with anti-Alzheimer’s disease properties
Songlan Gao, Honglei Zhang, Na Li, et al.
Journal of Pharmaceutical Analysis (2024), pp. 101043-101043
Open Access
Neuroprotective Potential of Aminonaphthoquinone Derivatives Against Amyloid Beta-Induced Neuronal Cell Death Through Modulation of SIRT1 and BACE1
Setthawut Apiraksattayakul, Ratchanok Pingaew, Veda Prachayasittikul, et al.
Neurochemical Research (2024) Vol. 50, Iss. 1
Open Access
Recent Advances in the Search for Effective Anti-Alzheimer’s Drugs
Martyna Ogos, Dorota Stary, Marek Bajda
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 157-157
Open Access
Page 1 - Next Page

Scroll to top